Lōkahi Therapeutics™ Expands ai² Futures Lab™ Asset Origination Network Through Collaboration with San Diego State University Fowler College of Business
Glucotrack's subsidiary Lōkahi Therapeutics added San Diego State University's Fowler College of Business to its ai² Futures Lab, a program that sources overlooked or deprioritized drug candidates through academic partnerships. In its first year the program engaged 64 students and identified more than 45 potential assets, several of which advanced into active pipeline discussions, which management called encouraging early validation of the model.
Key figures
- Potential assets identified
- more than 45
- Students engaged first year
- 64
- Assets in active pipeline discussions
- several
AI analysis
Red flags2 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.